Next Step for Phase 1 GBR 1342 Studies - Identify the maximum tolerated dose to proceed to Phase 2 - 101931

Spotlight
Video

Next Step for Phase 1 GBR 1342 Studies - Identify the maximum tolerated dose to proceed to Phase 2

ASHReport has 256 videos Subscribe Here

Loading........
Description: Joshua Richter, MD from John Theurer Cancer Center discusses next step for Phase 1 GBR 1342 studies and identifying the maximum tolerated dose to proceed to Phase 2 at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/23/18
Added : 5 months ago
Category : Multiple Myeloma